MindWalk Reports Strong Q3 Revenue Growth, Reduced Net Loss, and Extended Cash Runway
HYFT has more than doubled off its 52-week low of $0.316.
Summary
MindWalk Holdings Corp. announced strong Q3 revenue growth of 52% and a significantly reduced net loss, extending its cash runway to over one year, despite identifying a material weakness in internal controls.
Key Events · Earnings and Guidance · HYFT
-
Strong Q3 Financial Performance
Revenue for the three months ended January 31, 2026, increased by 52% to $4.2 million CAD, and the net loss significantly decreased to $3.9 million CAD from $21.5 million CAD in the prior year's comparable period. Basic and diluted loss per share was $(0.08) CAD.
-
Extended Cash Runway
The company reported $14.1 million CAD in cash on hand as of January 31, 2026, which is expected to fund operations for at least one year.
-
ATM Program Utilized
MindWalk sold 533,969 common shares under its At-The-Market (ATM) facility, generating gross proceeds of $1.1 million CAD during the quarter.
-
Material Weakness in Internal Controls
Management identified a material weakness in internal controls over financial reporting due to insufficient resources for complex technical accounting issues, with remediation efforts underway.
Analysis · HYFT · Life Sciences
MindWalk Holdings Corp. reported significant operational improvements in its third quarter, with revenue increasing by 52% to $4.2 million CAD compared to the prior year. The company also substantially reduced its net loss to $3.9 million CAD, down from $21.5 million CAD in the same period last year (which included a large asset impairment). This improved financial performance, coupled with $14.1 million CAD in cash on hand, provides the company with an expected cash runway of at least one year. While the company continues to operate at a net loss and disclosed a material weakness in internal controls over financial reporting, it is actively implementing remediation measures. The company also utilized its At-The-Market (ATM) facility, selling 533,969 common shares for $1.1 million CAD during the quarter, providing additional capital.
At the time of this filing, HYFT was trading at $1.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $59.8M. The 52-week trading range was $0.32 to $3.25. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.